SANO Diagnostics is a pioneering startup that focuses on developing a disposable, cost-effective point-of-care diagnostic platform for chronic wounds, notably diabetic foot ulcers and pressure ulcers. The company utilizes cutting-edge technology to measure wound protease-related biochemistry, providing clinicians with vital information about their patients' current wound status and progression. SANO's flagship diagnostic aims to personalize treatment, accelerating the healing process, and significantly reducing treatment costs. Additionally, the company is venturing into the equine market with an early-stage diagnostic product. SANO Diagnostics, founded in 2013, operates in the Health Care industry and has garnered recognition through various awards and accolades. The company's notable achievements include winning the 1st place at the Harvard Business School Boston Club and the Mass Medical Device Development Center, as well as being a Finalist at the Harvard Business School New Venture Competition. SANO also secured a $50.00K grant investment on 29 October 2014 from MassChallenge. Overall, SANO Diagnostics is positioned as a promising player in the healthcare industry with its innovative approach to wound care diagnostics, backed by notable accolades and investments.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $50.00K | 1 |
|
29 Oct 2014 |
We care about your data, and we'd love to use cookies make your experience better.
